OPTT, a presenting company at the 2022 OBIO Investment Summit, selected for Morgan Stanley's Multicultural Innovation Lab

Morgan Stanley recently announced the seventh cohort of the Multicultural Innovation Lab, an accelerator program for technology and technology-enabled startups in the post‐seed to Series B funding rounds. The program targets startups with a multicultural or woman founder, co‐founder, CTO or other C-suite member that is developing innovative solutions across sectors. The companies that have been selected for the Winter 2022 cohort include OPTT, a company that presented at the 2022 OBIO Investment Summit.

OPTT is a provider of comprehensive hybrid digital care plans augmented by AI for proactive triage and monitoring of patients to simplify the digital-first delivery of mental health services for care teams.